Clinical Trials Information System: Streamlining Clinical Trial Submissions

ctis will be the single entry point n.w
1 / 6
Embed
Share

Learn about CTIS, the single entry point for submitting clinical trial information in the EU and EEA. Discover how sponsors can prepare for CTIS, register, and navigate the process seamlessly. Get insights on transitioning to CTIS and the key functionalities it offers.

  • Clinical Trials
  • CTIS
  • EU Regulations
  • Clinical Trial Applications
  • EMA

Uploaded on | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.

E N D

Presentation Transcript


  1. CTIS will be the single entry point for submitting clinical trial information in the EU and the European Economic Area (EEA). CTIS contains: A public website where anyone can search for information on clinical trials A Sponsor workspace where clinical trial sponsors and the organisations that work with them can apply for and manage a clinical trial in up to 30 EU/EEA countries An Authority workspace for EU Member States, EEA countries and the European Commission to assess, authorise and oversee clinical trials Open access Secure access Classified as internal/staff & contractors by the European Medicines Agency

  2. The Clinical Trials Regulation foresees a 3-year transition period to CTIS: Transition year 1 Transition years 2 and 3 31 Jan 2022 31 Jan 2023 31 Jan 2025 Clinical Trials Regulation enters into application and CTIS goes live All initial clinical trial applications must be submitted through CTIS All ongoing clinical trials must be transferred to CTIS Classified as internal/staff & contractors by the European Medicines Agency

  3. How clinical trials are processed in CTIS Clinical trial sponsors who want to gain approval to run a clinical trial in one or more EU/EEA countries submit a single clinical trial application form and supporting dossier through CTIS. The submission of the single clinical trial application includes the public registration of the trial. National regulators of EU/EEA Member States assess the clinical trial application. If they authorise the application, the trial can begin. CTIS supports the day-to-day business processes of EU Member States, EEA countries and sponsors throughout the lifecycle of a clinical trial. It will provide regulatory oversight of trials and tools for supervision and monitoring. Classified as internal/staff & contractors by the European Medicines Agency

  4. How to prepare for CTIS Sponsors can consult the CTIS Sponsor Handbook for guidance on how to prepare for CTIS. The CTIS online training programme is another key resource. The guide to the CTIS training material catalogue on the CTIS training programme page provides an overview of the training catalogue. Classified as internal/staff & contractors by the European Medicines Agency

  5. How to register for CTIS 1. Ensure you have an EMA account You already have an EMA account if you use EMA systems like Eudravigilance or the substances, products, organisations and referentials database (SPOR) If you do not already have an account, register via EMA Account Management 2. Choose your user management approach (organisation vs trial centric) Organisation-centric allows for the management of users by an administrator at the organisation level rather than at the level of an individual trial. It is intended for organisations that will run several trials in CTIS 3. For the organisation-centric approach, ensure your organisation is registered in OMS and register your first High-Level Administrator via EMA Account Management 4. Ensure your product is registered in XEVMPD View the Getting started with CTIS quick guide here. Classified as internal/staff & contractors by the European Medicines Agency

  6. Useful links Information on CTIS: https://www.ema.europa.eu/en/human-regulatory/research- development/clinical-trials/clinical-trials-regulation CTIS training and support: https://www.ema.europa.eu/en/human-regulatory/research- development/clinical-trials/clinical-trials-information-system-training-support Online modular training on CTIS functionalities: https://www.ema.europa.eu/en/human- regulatory/research-development/clinical-trials/clinical-trials-information-system-ctis-online- modular-training-programme CTIS Sponsor Handbook: https://www.ema.europa.eu/en/human-regulatory/research- development/clinical-trials/clinical-trials-information-system-training-support#handbook-for- clinical-trial-sponsors-section CTIS Newsletter: https://www.ema.europa.eu/en/news-events/publications/newsletters#clinical- trials-information-system-(ctis)-highlights-section For information on the Clinical Trials Regulation: EudraLex - Volume 10 - Clinical trials guidelines | Public Health (europa.eu) and Draft - Questions and Answers Document - Regulation (EU) 536/2014 Version 4.1 (September 2021) Classified as internal/staff & contractors by the European Medicines Agency

Related


More Related Content